Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Pharmacogenet Genomics. 2011 Jan;21(1):1–9. doi: 10.1097/fpc.0b013e328340bc5a

Figure 1.

Figure 1

CONSORT Diagram of Study Sample. Initial samples dropped from the genotype analysis included (1) five subjects missing clinical data, (2) three subjects who were duplicates, and (3) four subjects' whose DNA results did not match reported gender. To define the “remission analysis sample,” 411 additional subjects were excluded because (1) 61 were medication non-compliant, (2) 33 had a baseline QIDS-C16 <10, (3) 218 dropped out within the first six weeks, and (4) 99 were part of an ethnically diverse group. From reference [16] with permission.